A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis

Archives of Neurology

Volumn 61, Issue 11, 2004, Pages 1773-1776

  Ataka, Suzuka ^a   Tomiyama, Takami ^a   Takuma, Hiroshi ^a   Yamashita, Takenari ^a   Shimada, Hiroyuki ^a   Tsutada, Tsuyoshi ^a   Kawabata, Koichi ^a   Mori, Hiroshi ^a   Miki, Takami ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MUTANT PROTEIN; PRESENILIN 1; PRESENILIN 2;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPASTIC PARAPLEGIA; VISUAL ACUITY;

ADULT; AGE OF ONSET; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; DNA MUTATIONAL ANALYSIS; HUMANS; MALE; MEMBRANE PROTEINS; PARAPARESIS, SPASTIC; POINT MUTATION; PRESENILIN-1; VISION DISORDERS;

EID: 7744233995     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.11.1773     Document Type: Article

References (20)

1. Kwok JB, Taddei K, Hallupp M, et al. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport. 1997;8:1537-1542.
2. Crook R, Verkkoniemi A, Perez-Tur J, et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 1998;4:452-455.
3. Houlden H, Baker M, McGowan E, et al. Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol. 2000;48:806-808.
4. Verkkoniemi A, Somer M, Rinne JO, et al. Variant Alzheimer's disease with spastic paraparesis: clinical characterization. Neurology. 2000;54:1103-1109.
5. Smith MJ, Kwok JB, McLean CA, et al. Variable phenotype of Alzheimer's disease with spastic paraparesis. Ann Neurol. 2001;49:125-129.
6. Rogaeva EA, Fafel KC, Song YQ, et al. Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology. 2001;57:621-625.
7. Matsubara-Tsutsui M, Yasuda M, Yamagata H, et al. Molecular evidence of presenilin 1 mutation in familial early onset dementia. Am J Med Genet. 2002;114:292-298.
8. O'Riordan S, McMonagle P, Janssen JC, et al. Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities. Neurology. 2002;59:1108-1110.
9. Tabira T, Chui de H, Nakayama H, Kuroda S, Shibuya M. Alzheimer's disease with spastic paresis and cotton wool type plaques. J Neurosci Res. 2002;70:367-372.
10. Jacquemont ML, Campion D, Hahn V, et al. Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease. J Med Genet. 2002;39:E2.
11. Assini A, Terreni L, Borghi R, et al. Pure spastic paraparesis associated with a novel presenilin 1 R278K mutation. Neurology. 2003;60:150.
12. Sodeyama N, Iwata T, Ishikawa K, et al. Very early onset Alzheimer's disease with spastic paraparesis associated with a novel presenilin 1 mutation (Phe237lle). J Neurol Neurosurg Psychiatry. 2001;71:556-557.
13. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 1990;31:545-548.
14. Okochi M, Ishii K, Usami M, et al. Proteolytic processing of presenilin-1 (PS-1) is not associated with Alzheimer's disease with or without PS-1 mutations. FEBS Lett. 1997;418:162-166.
15. Tamaoka A, Sawamura N, Fukushima T, et al. Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. J Neurol Sci. 1997;148:41-45.
16. Jensen M, Schröder J, Blomberg M, et al. Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression. Ann Neurol. 1999;45:504-511.
17. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 1996;2:864-870.
18. Steiner H, Revesz T, Neumann M, et al. A pathogenic presenilin-1 deletion causes aberrant Abeta 42 production in the absence of congophilic amyloid plaques. J Biol Chem. 2001;276:7233-7239.
19. Nussbaum RL, McInnes RR, Willard HF. Genetic variation in individuals: mutation and polymorphism. In: Thompson and Thompson Genetics in Medicine. 6th ed. Philadelphia, Pa: WB Saunders Co; 2001:79-94.
20. Levine DN, Lee JM, Fisher CM. The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology. 1993;43:305-313.